Anti-inflammatory effect of lemon mucilage: In vivo and in vitro studies

Immunopharmacology and Immunotoxicology

Volumn 27, Issue 4, 2005, Pages 661-670

  Galati, Enza Maria ^a   Cavallaro, Antonia ^a   Ainis, Tommaso ^a   Tripodo, Maria Marcella ^a   Bonaccorsi, Irene ^a   Contartese, Giuseppe ^a   Taviano, Maria Fernanda ^a   Fimiani, Vincenzo ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARRAGEENAN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LEMON EXTRACT; OXYGEN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE D; PLANT EXTRACT; SUPEROXIDE; UNCLASSIFIED DRUG; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD ANALYSIS; CENTRIFUGATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; ENZYME INHIBITION; EXPERIMENTAL RAT; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LEMON; LEMON JUICE; LEMON MUCILAGE; LEUKOCYTE ACTIVATION; MALE; NEUTROPHIL; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PULP PROCESSING; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARRAGEENAN; CITRUS; DISEASE MODELS, ANIMAL; EDEMA; MALE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PLANT EXTRACTS; RATS; RATS, WISTAR; SUPEROXIDES; TIME FACTORS;

ANIMALIA; CITRUS LIMON;

EID: 32344447545     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.1080/08923970500418919     Document Type: Article

References (32)

1. Sreenath, H.K.; Crandall, P.G.; Baker, R.A. Utilization of citrus by-products and waste as beverage clouding agents. J. Ferment. Bioeng. 1995, 80(2), 190-194.
2. Fernandez-Lopez, J.; Fernandez-Ginès, J.M.; Aleson-Carbonell, L.; Sendra, E.; Sayas-Barberà, E.; Pèrez-Alvarez, J.A. Application of functional citrus by-products to meat products. Trends Food Sci. Technol. 2004, 15, 176-185.
3. El-Nawawi, S.A.; Heikal, Y.A. Production of pectin pomace and recovery of leach liquids from orange peel. J. Food Eng. 1996, 28, 341-347.
4. Galati, E.M.; Mondello, M.R.; Monforte, M.T.; Galluzzo, M.; Miceli, N.; Tripodo, M.M. Effect of Opuntia ficus indica (L.) Mill, cladodes in the wound healing process. J. Prof. Assn. Cactus Develop. 2003, 5, 1-16; (www.jpacd.org).
5. Galati, E.M.; Monforte, M.T.; Tripodo, M.M.; d'Aquino, A.; Mondello, M.R. Antiulcer activity of Opuntia ficus indica (L.) Mill. (Cactaceae): ultrastructural study. J. Ethnopharmacol. 2001, 76, 1-9.
6. Yamada, H.; Hirano, M.; Kiyohara, H. Partial structure of an anti-ulcer pectic polysaccharide from the roots of Buplenum falcatum L. Carbohyd. Res. 1991, 219, 173-192.
7. Atal, C.K.; Sharma, M.L.; Kaul, A.; Khajjuria, A. Immunomodulatoryng agents of plants origin: I Preliminary screening. J. Ethnopharmacol. 1986, 18, 133-141.
8. 't-Hart, L.A.; van den Berg, A. J. J.; Kuis, L.; van Dijk, H.; Labadie, R.P. An anti-complementary polysaccharide with immunological adjuvant activity from the leaf parenchyma gel of Aloe vera. Planta Medica 1989, 55, 509-512.
9. Vazquez, B.; Avila, G.; Segura, D.; Escalante, B. Anti-inflammatory activity of extract from Aloe vera gel. J.Ethnopharmacol. 1996, 55, 69-75.
10. Tzianabios, A.O. Polysaccharide immunomodulators as therapeutic agents: structural aspects and biological function. Clin. Microbiol. Rev. 2000, 13, 523-533.
11. Winter, C.A.; Risley, E.A.; Nuss, G.W. Carrageenin-induced oedema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. Med. 1962, 111, 544-547.
12. Bellavite, P.; Dri, P.; Berton, G.; Zabucchi, G. The measurement of superoxide anion production by granulocytes in whole blood. A clinical test for the evaluation of phagocyte function and serum opsonic capacity. Eur. J. Clin. Invest. 1983, 13, 363-374.
13. da Silva, B.S.; Parente, J.P. Bioactive polysaccharides from Costus spicatus. Carbohyd. Polym. 2003, 51, 239-242.
14. Paulsen, B.S. Biologically active polysaccharides as possible lead compounds. Phytochem. Rev. 2002, 1, 379-387.
15. Reynolds, T.; Dweck, A.C. Aloe vera leaf gel: a review update. J. Ethnopharmacol. 1999, 68, 3-37.
16. Vinegar, R.; Truax, J.F.; Selph, J.L.; Johnston, P.R.; Venable, A.L.; McKenzie, K.K. Pathway to carragenan-induced inflammation in the hind limb of the rat. Fed. Proc. 1987, 46, 118-126.
17. Boxer, G.J.; Curnutte, J.T.; Boxer, L.A. Polymorphonuclear leukocyte function. Hosp. Practice. 1985, 40, 69-90.
18. Haslett, C.; Savill, J.S.; Meagher, L. The neutrophil. Curr. Opin. Immunol. 1989, 2, 10-18.
19. Bernofsky, C. Nucleotide chloramines and neutrophil-mediated cytotoxicity. FASEB J 1991, 5, 295-300.
20. Dallegri, F.; Ottonello, L.; Dapino, P.; Bevilacqua, M. The anti-inflammatory drug nimesulide rescues alpha-1-proteinase inhibitor from oxidative inactivation by phagocytosing neutrophils. Respiration 1992, 59, 1-4.
21. Rossi, F. The O2-forming NADPH-oxidase of phagocyte nature, mechanism of activation and function. Biochim. Biophys. Acta. 1986, 853, 65-89.
22. Berridge, M.J. Inositol triphosphate and diacylglycerol: two interacting second messengers. Annu. Rev. Biochem. 1987, 56, 159-193.
23. Cockcroft, S. G-protein-regulated phospholipase C, D and A2-mediated signalling in neutrophils. Biochim. Biophys. Acta. 1992, 1113, 135-160.
24. Bokoch, G.M. Chemoattractant signalling and leukocyte activation. Blood 1995, 86, 1649-1660.
25. Zu, L.; Qi, J.; Gilchrist, A.; Fernandez, G.A.; Vazquez-Abad, D.; Kreutzer, D.L.; Huang, C.; Sha'afi, R.I. p38 Mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-α or FMLP stimulation. J. Immunol. 1998, 160, 1982-1989.
26. Bechoua, S.; Daniel, L.W. Phospholipase D is required in the signalling pathway leading to p38MAPK activation in neutrophil-like HL-60 cells, stimulated by N-formyl-methionyl-leucyl-phenilalanine. J. Biol. Chem. 2001, 34, 31752-31759.
27. Bauldry, S.A.; Bass, D.A.; Cousart, S.L.; McCall, C.E. Tumor necrosis factor alpha priming of phospholipase D in human neutrophils. Correlation between phosphatidic acid production and superoxide generation. J. Biol. Chem. 1991, 266, 4173-4179.
28. Rossi, F.; Grzeskowiak, M.; Della Bianca, V.; Calzetti, F.; Gandini, G. Phosphatidic acid and not diacylglycerol generated by phospholipase D is functionally linked to the activation of the NAFPH oxidase by FMLP in human neutrophils. Biochem. Biophys. Res. Commun. 1990, 168, 320-327.
29. Rais, S.; Pedruzzi, E.; Dang, M.C.; Giroud, J.P.; Hakim, J.; Perianin, A. Priming of phosphatidic acid production by staurosporine in f-Met-Leu-Phe-stimulated human neutrophils: correlation with respiratory burst. Cell Signal 1998, 10, 121-129.
30. Djerdjouri, B.; Lenoir, M.; Giroud, J.P.; Perianin, A. Contribution of mitogen-activated proteinkinase to stimulation of phospholipase D by the chemotactic peptide f-Met-Leu-Phe in human neutrophils. Biochem. Biophys. Res. Commun. 1999, 264, 371-375.
31. Waki, K.; Inanami, O.; Yamamori, T.; Kuwabara, M. Extracellular signal-regulated kinase 1/2 is involved in the activation of NADPH oxidase induced by FMLP but not by complement receptor 3 in rat neutrophils. Free Radic. Res. 2003, 37, 665-671.
32. Wang, J.P.; Chang, L.C.; Lin, Y.L.; Hsu, M.F.; Chang, C.Y.; Huang, L.J.; Kuo, S.C. Investigation of the cellular mechanism of inhibition of formyl-methionyl-leucyl-phenylalanine-induced superoxide anion generation in rat neutrophils by 2-benzyloxybenzaldehyde. Biochem. Pharmacol. 2003, 65, 1043-1051.